Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 10-Apr-24 9:40 PM View:  | Cartesian Therapeutics, Inc. (RNAC) | 08-Apr-24 | Option Exercise | 4,130,850 | -- | -- | 275% 1.5M to 5.63M | |
| 10-Apr-24 9:40 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 08-Apr-24 | Option Exercise | 826,169 | -- | -- | 15% 5.63M to 6.46M | |
| 10-Apr-24 9:40 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 08-Apr-24 | Option Exercise | 123,925 | -- | -- | (2%) 6.46M to 6.34M | |
| 10-Apr-24 9:40 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 08-Apr-24 | Option Exercise | 24,785 | -- | -- | (< 1%) 6.34M to 6.31M | |
| 26-Mar-24 4:32 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 26-Mar-24 | Option Exercise | 1,970,440 | $1.46 | $2,876,850.00 | 5% 38.63M to 40.6M | |
| 20-Mar-24 5:09 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 18-Mar-24 | Private Purchase | 19,044 | $0.60 | $11,397.80 | < 1% 38.61M to 38.63M | |
| 28-Mar-24 5:11 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 18-Mar-24 | Purchase | 800 | $0.61 | $488.00 | < 1% 40.62M to 40.62M | |
| 18-Mar-24 5:29 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 15-Mar-24 | Purchase | 537,500 | $0.59 | $314,545.00 | 1% 38.07M to 38.61M | |
| 28-Mar-24 5:11 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 15-Mar-24 | Purchase | 1,200 | $0.56 | $672.00 | < 1% 40.62M to 40.62M | |
| 18-Mar-24 5:29 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 14-Mar-24 | Private Purchase | 648,372 | $0.54 | $351,677.00 | 2% 37.43M to 38.07M | |
| 28-Mar-24 5:11 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 14-Mar-24 | Purchase | 2,000 | $0.53 | $1,061.00 | < 1% 40.62M to 40.62M | |
| 28-Mar-24 5:11 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 13-Mar-24 | Purchase | 3,200 | $0.58 | $1,867.84 | < 1% 40.61M to 40.62M | |
| 28-Mar-24 5:11 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 12-Mar-24 | Purchase | 1,200 | $0.61 | $734.64 | < 1% 40.61M to 40.61M | |
| 28-Mar-24 5:11 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 11-Mar-24 | Purchase | 1,200 | $0.65 | $784.92 | < 1% 40.61M to 40.61M | |
| 28-Mar-24 5:11 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 08-Mar-24 | Purchase | 4,800 | $0.66 | $3,186.72 | < 1% 40.61M to 40.61M | |
| 28-Mar-24 5:11 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 07-Feb-24 | Purchase | 2,400 | $0.66 | $1,575.12 | < 1% 40.6M to 40.61M | |
| 28-Mar-24 5:11 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 06-Feb-24 | Purchase | 800 | $0.65 | $520.00 | < 1% 40.6M to 40.6M | |
| 28-Mar-24 5:11 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 17-Jan-24 | Private Purchase | 800 | $0.69 | $552.00 | < 1% 40.6M to 40.6M | |
| 04-Jan-24 5:06 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 02-Jan-24 | Grant | 178,000 | -- | -- | < 1% 37.25M to 37.43M | |
| 15-Nov-23 5:20 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 15-Nov-23 | Grant | 24,785 | $403.47 | $10,000,000.00 | < 1% 37.25M to 37.27M | |
| 15-Nov-23 5:20 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 15-Nov-23 | Grant | 123,925 | $403.47 | $50,000,000.00 | < 1% 37.27M to 37.4M | |
| 30-Jun-23 7:03 PM View: | Morphic Holding, Inc. (MORF) | 28-Jun-23 | Acquisition (other) | 429 | -- | -- | < 1% 7.42M to 7.42M | |
| 30-Jun-23 7:03 PM View: | Morphic Holding, Inc. (MORF) | 28-Jun-23 | Acquisition (other) | 429 | -- | -- | < 1% 7.42M to 7.42M | |
| 04-May-23 10:00 PM View: | Morphic Holding, Inc. (MORF) | 03-May-23 | Market Purchase | 1,050,000 | $45.00 | $47,250,000.00 | 16% 6.37M to 7.42M | 5% |
| 13-Feb-23 4:14 PM View: | Morphic Holding, Inc. (MORF) | 13-Feb-23 | Grant | 42,432 | $35.35 | $1,499,970.00 | < 1% 5.52M to 5.56M | |
| 13-Feb-23 4:14 PM View: | Morphic Holding, Inc. (MORF) | 13-Feb-23 | Grant | 806,223 | $35.35 | $28,500,000.00 | 14% 5.56M to 6.37M | |
| 13-Apr-22 9:07 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 11-Apr-22 | Purchase | 6,681,600 | -- | -- | 22% 30.57M to 37.25M | |
| 17-Dec-21 4:36 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 15-Dec-21 | Market Purchase | 211,190 | $2.99 | $631,099.00 | < 1% 30.36M to 30.57M | 4% |
| 13-Dec-21 5:16 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 13-Dec-21 | Market Purchase | 14,592 | $2.98 | $43,491.50 | < 1% 30.34M to 30.36M | < 1% |
| 13-Dec-21 5:16 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 10-Dec-21 | Market Purchase | 58,681 | $2.99 | $175,439.00 | < 1% 30.28M to 30.34M | < 1% |
| 13-Dec-21 5:16 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 09-Dec-21 | Market Purchase | 3,748,000 | $3.06 | $11,468,900.00 | 14% 26.53M to 30.28M | (2%) |
| 20-Aug-21 7:08 PM View: | Morphic Holding, Inc. (MORF) | 20-Aug-21 | Market Purchase | 11,620 | $56.79 | $659,944.00 | < 1% 5.51M to 5.52M | (< 1%) |
| 20-Aug-21 7:08 PM View: | Morphic Holding, Inc. (MORF) | 19-Aug-21 | Market Purchase | 33,000 | $56.52 | $1,865,010.00 | < 1% 5.48M to 5.51M | (< 1%) |
| 20-Aug-21 7:08 PM View: | Morphic Holding, Inc. (MORF) | 18-Aug-21 | Market Purchase | 30,307 | $55.70 | $1,688,200.00 | < 1% 5.45M to 5.48M | 1% |
| 26-May-21 5:21 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 26-May-21 | Market Purchase | 926,170 | $4.00 | $3,705,700.00 | 4% 25.61M to 26.53M | (11%) |
| 26-May-21 7:02 PM View: | Morphic Holding, Inc. (MORF) | 26-May-21 | Market Purchase | 25,000 | $46.97 | $1,174,300.00 | < 1% 6.23M to 6.26M | (4%) |
| 26-May-21 5:21 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 25-May-21 | Market Purchase | 383,830 | $3.55 | $1,362,100.00 | 2% 25.22M to 25.61M | < 1% |
| 26-May-21 7:02 PM View: | Morphic Holding, Inc. (MORF) | 25-May-21 | Market Purchase | 65,000 | $45.87 | $2,981,380.00 | 1% 6.17M to 6.23M | (1%) |
| 26-May-21 5:21 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 24-May-21 | Market Purchase | 590,000 | $3.38 | $1,992,080.00 | 2% 24.63M to 25.22M | 6% |
| 26-May-21 7:02 PM View: | Morphic Holding, Inc. (MORF) | 24-May-21 | Market Purchase | 40,000 | $46.51 | $1,860,310.00 | < 1% 6.13M to 6.17M | (3%) |
| 25-May-21 4:27 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 21-May-21 | Market Purchase | 2,773,480 | $3.19 | $8,847,400.00 | 13% 21.86M to 24.63M | 8% |
| 25-May-21 7:03 PM View: | Morphic Holding, Inc. (MORF) | 21-May-21 | Market Purchase | 232,295 | $45.50 | $10,569,400.00 | 5% 5.08M to 5.32M | (< 1%) |
| 08-Mar-21 7:12 PM View: | Morphic Holding, Inc. (MORF) | 05-Mar-21 | Market Purchase | 100,000 | $70.00 | $7,000,000.00 | 2% 4.98M to 5.08M | < 1% |
| 23-Oct-20 5:12 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 23-Oct-20 | Market Purchase | 994,488 | $2.71 | $2,699,740.00 | 5% 20.87M to 21.86M | 20% |
| 23-Oct-20 5:12 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 22-Oct-20 | Market Purchase | 1,770,200 | $2.63 | $4,656,700.00 | 9% 19.1M to 20.87M | 24% |
| 23-Oct-20 5:12 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 21-Oct-20 | Market Purchase | 880,000 | $2.50 | $2,199,470.00 | 5% 18.22M to 19.1M | 31% |
| 20-Oct-20 6:07 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 20-Oct-20 | Market Purchase | 910,000 | $2.21 | $2,013,190.00 | 5% 17.31M to 18.22M | 48% |
| 20-Oct-20 6:07 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 19-Oct-20 | Market Purchase | 759,500 | $2.36 | $1,795,000.00 | 5% 16.55M to 17.31M | 38% |
| 20-Oct-20 6:07 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 16-Oct-20 | Market Purchase | 218,196 | $2.42 | $528,034.00 | 1% 16.33M to 16.55M | 35% |
| 14-Oct-20 4:18 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 09-Oct-20 | Market Purchase | 276,703 | $2.00 | $552,465.00 | 2% 16.05M to 16.33M | 64% |